EU agency: AstraZeneca vaccine safe, will add clot warning
People rest after being vaccinated with the AstraZeneca COVID-19 vaccine in a mass vaccination site at the Brabanthal event center in Heverlee, Belgium, Wednesday, March 17, 2021. The European Commission President Ursula von der Leyen criticized Anglo-Swedish vaccine-maker AstraZeneca on Wednesday, accusing the embattled pharmaceutical company of delaying Europe's coronavirus vaccination campaign and warning that the EU is weighing export bans to ensure supplies. (AP Photo/Francisco Seco)

People rest after being vaccinated with the AstraZeneca COVID-19 vaccine in a mass vaccination site at the Brabanthal event center in Heverlee, Belgium, Wednesday, March 17, 2021. The European Commission President Ursula von der Leyen criticized Anglo-Swedish vaccine-maker AstraZeneca on Wednesday, accusing the embattled pharmaceutical company of delaying Europe's coronavirus vaccination campaign and warning that the EU is weighing export bans to ensure supplies. (AP Photo/Francisco Seco)

Mar. 17, 2021 12:55 PM EDT
Pharmacy Technician Katrina Bonwick draws a does of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Pharmacy Technician Katrina Bonwick draws a does of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Mar. 18, 2021 07:50 AM EDT
A man receives his first dose of the AstraZeneca COVID-19 vaccine in a mass vaccination site at the Brabanthal event center in Heverlee, Belgium, Wednesday, March 17, 2021. The European Commission President Ursula von der Leyen criticized Anglo-Swedish vaccine-maker AstraZeneca on Wednesday, accusing the embattled pharmaceutical company of delaying Europe's coronavirus vaccination campaign and warning that the EU is weighing export bans to ensure supplies. (AP Photo/Francisco Seco)

A man receives his first dose of the AstraZeneca COVID-19 vaccine in a mass vaccination site at the Brabanthal event center in Heverlee, Belgium, Wednesday, March 17, 2021. The European Commission President Ursula von der Leyen criticized Anglo-Swedish vaccine-maker AstraZeneca on Wednesday, accusing the embattled pharmaceutical company of delaying Europe's coronavirus vaccination campaign and warning that the EU is weighing export bans to ensure supplies. (AP Photo/Francisco Seco)

Mar. 17, 2021 12:53 PM EDT
A vial and syringes ready for use of the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

A vial and syringes ready for use of the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)

Mar. 18, 2021 07:50 AM EDT
The exterior of the European Medicines Agency, EMA, is seen in Amsterdam, Netherlands, Tuesday March 16, 2021. At least a dozen countries including Germany, France, Italy and Spain have now temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports last week that some people in Denmark and Norway who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available don't suggest the vaccine caused the clots and that people should continue to be immunized. (AP Photo/Peter Dejong)

The exterior of the European Medicines Agency, EMA, is seen in Amsterdam, Netherlands, Tuesday March 16, 2021. At least a dozen countries including Germany, France, Italy and Spain have now temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports last week that some people in Denmark and Norway who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available don't suggest the vaccine caused the clots and that people should continue to be immunized. (AP Photo/Peter Dejong)

Mar. 16, 2021 11:31 AM EDT
Pharmacy Technician Katrina Bonwick administers a dose of the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)

Pharmacy Technician Katrina Bonwick administers a dose of the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)

Mar. 18, 2021 07:54 AM EDT